Treatment with fluoroquinolones or with beta-lactam-beta-lactamase inhibitor combinations is a risk factor for isolation of extended-spectrum-beta-lactamase-producing Klebsiella species in hospitalized patients.

Treatment with fluoroquinolones or with beta-lactam-beta-lactamase inhibitor combinations is a risk factor for isolation of extended-spectrum-beta-lactamase-producing Klebsiella species in hospitalized patients.

Item

http://www.wikidata.org/entity/Q33826293

Q33826293

about

Clinical and Molecular Epidemiology of Extended-Spectrum Beta-Lactamase-Producing Klebsiella spp.: A Systematic Review and Meta-Analyses Ciprofloxacin prophylaxis in high risk neutropenic patients: effects on outcomes, antimicrobial therapy and resistance Stable susceptibility to aminoglycosides in an age of low level, institutional use.Comparison of the MALDI Biotyper system using Sepsityper specimen processing to routine microbiological methods for identification of bacteria from positive blood culture bottles.Epidemiological interpretation of studies examining the effect of antibiotic usage on resistance Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis.Public health risks of enterobacterial isolates producing extended-spectrum β-lactamases or AmpC β-lactamases in food and food-producing animals: an EU perspective of epidemiology, analytical methods, risk factors, and control options.Modern diagnostic methods for urinary tract infections.The Impact of Antibiotic Stewardship Programs in Combating Quinolone Resistance: A Systematic Review and Recommendations for More Efficient Interventions.Antibiotic Therapy for Acute Watery Diarrhea and Dysentery.Genetic characterization of fluoroquinolone resistant Escherichia coli from urban streams and municipal and hospital effluents.Escherichia coli and Klebsiella pneumoniae bacteremia in patients with neutropenic fever: factors associated with extended-spectrum β-lactamase production and its impact on outcome.Risk factors and scoring system for predicting bacterial resistance to cefepime as used empirically in haematology wards.Epidemiological factors associated with ESBL- and non ESBL-producing E. coli causing urinary tract infection in general practice.Identification of Gram-Negative Bacteria and Genetic Resistance Determinants from Positive Blood Culture Broths by Use of the Verigene Gram-Negative Blood Culture Multiplex Microarray-Based Molecular Assay.Antibiotic use and the risk of carbapenem-resistant extended-spectrum-{beta}-lactamase-producing Klebsiella pneumoniae infection in hospitalized patients: results of a double case-control study.Predictors of rectal carriage of carbapenem-resistant Enterobacteriaceae (CRE) among patients with known CRE carriage at their next hospital encounter.Scientific Opinion on the public health risks of bacterial strains producing extended-spectrum β-lactamases and/or AmpC β-lactamases in food and food-producing animals ECDC/EFSA/EMA first joint report on the integrated analysis of the consumption of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from humans and food-producing animals Are Fluoroquinolones Appropriate for the Treatment of Extended-Spectrum β-Lactamase-Producing Gram-Negative Bacilli?Risk factors associated with preoperative fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in liver transplant recipients

P2860

Q26781236-1CB010F2-2254-4A31-9FD5-C8D2606820D8 Q31125417-52C2183A-D8A5-4687-AC16-835DD1FFB2BE Q33939064-D0B74750-EAEC-4CCB-8A35-05854DC67BDC Q34097526-EB0828F3-C62C-4A1B-AC7A-D9C268746767 Q36757737-99F0E5E7-A4F1-4AA5-9E6A-2018C90BA485 Q37781944-33420E36-748C-49A3-9537-EC5F630ECB26 Q38067695-BE517DAA-E834-441A-90E4-A37C86CAEE7E Q38821537-45C0CFAA-426E-498F-9412-EFDCA833BA5D Q39183151-768A03E2-5B0E-445D-A9BD-33ADEEFEF137 Q40060459-7039ABBE-17CB-497F-978B-7BD1428BF303 Q40263075-E2DF8503-AF60-400B-B66D-3B9FFC271531 Q40267702-F97BD60A-B7E9-4B33-A880-CB628BAF685A Q40812219-558FA05F-0BD9-403C-B6B1-436BE7FEE71D Q40927633-22B0768D-3B5E-4C49-8D66-4140C7EF9FCB Q41213011-3C95A604-6CCB-4F04-85D1-4D31494F4FC4 Q43803132-CBB49650-6392-4ACD-8A09-4F46B60E18E4 Q44134572-467E6F19-056B-4FBF-8F1E-0DD9879FB719 Q47150482-EC4C0FE7-3307-48C7-B5D3-AE8BCD97E0E9 Q47156709-EA32611E-7DE5-4F51-AE38-A0A3E955E726 Q55251288-281D44B2-F003-4D18-909B-AC724A333718 Q56925190-1951EE98-7C8A-4E9B-9C47-FD26ACA6027D

P2860

Treatment with fluoroquinolones or with beta-lactam-beta-lactamase inhibitor combinations is a risk factor for isolation of extended-spectrum-beta-lactamase-producing Klebsiella species in hospitalized patients.

Item

http://www.wikidata.org/entity/Q33826293

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu